S4. Table T2 . Energetic cost of docked ligand conformations.
S5. Table T3 . Hydrogen bond parameters between K3.28(109) and each compounds' C-2 carbonyl oxygen.
S6. Table T4 . Hydrogen bond parameters between S7.39(285) and each compounds' carboxamide oxygen.
S7. Table T5 . Ligand-receptor aromatic stack parameters.
S8. Figure S1 . Drawings of the 1,8-naphthyridine scaffolds.
S9. Figure S2 . The global minima for antagonists: 17, 18, and 23. S10. Figure S3 . The global minima for agonists: A1, A2, 5, and 14. S11-S12. Ligand/Receptor Complexes S13. Figure Table T5 . Ligand-receptor aromatic stack distances and angles. Distance measurements describe the aromatic ring centroid to aromatic ring centroid distances. Planar Angle measurements describe the angle formed by the 2 planes (defined by the 2 aromatic rings). Aromatic interactions that did not occur are listed as N/A. Tables T3 and T4 for hydrogen bond details). Compound 17 is part of an aromatic cluster that links aromatics on TMH2 with aromatic residues on TMHs 3, 5 and 6. The aromatic cluster is composed of residues F2.57 (87) Table T5 for ligand-receptor aromatic stack details). F3.36 (117) Figure S6 for more details). The conformational cost associated with the bound conformation of 17 is 0.45 kcal/mol. Tables T3  and T4 for details]. Compounds 18 and 23 also interact with the same aromatic cluster that interacts with Compound 17 (see Table T5 for ligand-receptor aromatic stack details). 18 does not have a direct aromatic interaction with W6.48(258) as 17 and 23 do, but still completes the aromatic cluster, composed of residues F2.57 (87) Tables T3 and T4 for details]. The 1,8-naphthyridine ring has a titled-T aromatic stack with F2.57(87) and W5.43(194) , as well as an offset parallel aromatic stack with F3.36(117) [see Table T5 for ligand-receptor aromatic stack details]. In addition, F3.36(117) is in a tilted-T aromatic stack with W5.43(194) , which itself forms a tilted-T aromatic stack with W6.48(258). Unlike the antagonists/inverse agonists, Compound A2 does not sterically block a conformational change of the toggle switch residue W6.48(258) [χ1 in g+ trans]; this allows Compound A2 to act as an agonist. The conformational cost of associated with the bound conformation of A2 is 0.23 kcal/mol.
Figures S-5A, S-5C and S-5D illustrate the complexes of the CB2R in its activated state (R*) with the agonists, A1, 5 and 14, respectively. Each of the agonists binds in the TMH2-3-6-7 region of CB2, similarly as A2. All three of these compounds form hydrogen bonds with K3.28(109) and S7.39(285) [see Tables T3 and T4 for details]. These three compounds also participate in the same aromatic cluster as A2. Notable differences between the four agonists are lack of direct aromatic interactions for A1, 14, 5 with W5. 43(194) and W6.48(258) compared to A2 [see Table T5 for ligand-receptor aromatic stack details] and the higher conformational cost for compounds 14 and 5. The conformational cost associated with the bound conformations of A1, 14, 5 is 1.72 kcal/mol, 2.57 kcal/mol and 3.85 kcal/mol, respectively. Like A2, these three compounds do not sterically block a conformational change of the toggle switch residue W6.48(258) [χ1 in g+ trans]; this allows A1, 14, and 5 to act as agonists. The dissimilar binding affinity of 5 and 14, with compound 14 having a 39.2 fold better affinity than 5, may be due several reasons. First, the energetic cost of the docked conformation of 5 is 1.28 kcal/mol greater than the energetic cost of the docked conformation of 14. The greater conformational cost of 5 is mainly due to an intramolecular hydrogen bond between its alkyl-hydroxyl and its carbonyl oxygen formed in the global minimum conformation (please see Supplemental Figure S3 ). However, in the docked conformation of 5 this intramolecular hydrogen is broken and is not replaced by a new interaction within the receptor. Finally, while the results of our calculations suggests that 5 and 14 have similar interactions within the receptor, it is possible that the difference in interaction energies (between 5 and 14 with the receptor) are too small for Glide scoring functions to be able to distinguish (i.e. the difference between 5 and 14 is lost in the error bars of the Glide scoring functions: 1.7 -2.3 kcal/mol) and is not recovered during consecutive minimization 1 . This is especially likely, considering that part of difference of the binding affinities of 5 and 14 may be explained by the difference in conformational costs. 
